Perspective Therapeutics, Inc.

Historical 13F Holders

Symbol
CATX
CUSIP
46489V302
All holders as of
Q3 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 46489V302 since 12/18/2024, largest first.

Filer % of Class Filed
TCG Crossover GP II, LLC 13G
6.9% 2/6/2026
Event 2/3/2026
BlackRock, Inc. 13G 6.8% 7/29/2026
Event 6/30/2026
Qatar Investment Authority 13G 6.2% 2/5/2026
Event 2/4/2026
Commodore Capital LP 13G/A
5.5% 11/16/2026
Event 9/30/2026
Millennium Management LLC 13G/A
5.5% 8/13/2026
Event 8/7/2026
Avidity Partners Management LP 13G
5.3% 3/10/2026
Event 2/20/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (5)
Lantheus Holdings, Inc. 13D/A
3.9% 11/12/2026
Event 11/10/2026
Morgan Stanley 13G/A 2.6% 5/12/2026
Event 3/31/2026
State Street Corp 13G 1.8% 11/10/2026
Event 9/30/2026
FMR LLC 13G/A
0.4% 12/5/2025
Event 11/28/2025
Janus Henderson Group PLC 13G/A 0% 2/14/2025
Event 12/31/2024

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 118 79.9 M $220M
2026 Q2 129 87.0 M $297M
2026 Q1 137 84.6 M $351M
2025 Q4 115 36.3 M $102M
2025 Q3 103 42.5 M $146M
2025 Q2 98 42.2 M $145M
2025 Q1 111 44.1 M $93.9M
2024 Q4 135 47.1 M $150M
2024 Q3 129 49.0 M $654M
2024 Q2 104 38.5 M $384M